MRP Under Process
Official PMBI MRP is being updated for catalog code 2837.
Locate Jan Aushadhi KendraClinical Overview
Minoxidil oral tablets (5 mg, 10 mg) is a potent direct-acting peripheral arteriolar vasodilator. It acts by opening ATP-sensitive potassium channels in vascular smooth muscle, causing smooth muscle relaxation, profound vasodilation, and reflex sympathetic stimulation. Indicated for severe, refractory hypertension that has failed to respond to multidrug regimens (administered with a beta-blocker and loop diuretic), and used off-label in low doses for refractory androgenetic alopecia under strict specialist oversight.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Take orally with water, once or twice daily as prescribed. For hypertension, strictly co-administer with a beta-blocker (to prevent reflex tachycardia) and a diuretic (to prevent severe fluid retention).
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Hypertrichosis (growth of body/facial hair), edema, tachycardia, palpitations, headache. Rare/Severe: Boxed warning: Pericardial effusion, cardiac tamponade, severe angina pectoris, and congestive heart failure.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Black box warning: Can cause serious pericardial effusion, tamponade, and exacerbate angina; must be monitored closely by a specialist. Not for casual hair loss treatment without cardiovascular screening.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered dermatologist or qualified medical practitioner before initiating, altering, or substituting any topical or systemic dermatological treatment.
Minoxidil Solution 5%
Minoxidil topical solution (5% w/v) is a vasodilator and hair growth stimulant on the WHO Model List of Essential Medicines. It shortens the telogen (resting) phase, induces early entry into anagen (growth), increases hair follicle diameter, and enhances microvascular blood flow to the follicular papilla. Indicated for the treatment of androgenetic alopecia (pattern baldness) in men and women.
Minoxidil 5% and Finasteride 0.1% Topical Solution
Minoxidil (5%) and Finasteride (0.1%) topical solution is an advanced dual-action therapy for male androgenetic alopecia (male pattern baldness). Minoxidil stimulates dermal papilla vascular endothelial growth factor (VEGF), opens potassium channels, and prolongs the anagen (growth) phase of hair follicles, while topical finasteride selectively inhibits type II 5-alpha reductase in the scalp, lowering local dihydrotestosterone (DHT) levels by up to 70% with substantially less systemic exposure than oral finasteride. Indicated for male androgenetic alopecia of the vertex and anterior scalp.
Minoxidil Tablets 10mg
Minoxidil oral tablets (5 mg, 10 mg) is a potent direct-acting peripheral arteriolar vasodilator. It acts by opening ATP-sensitive potassium channels in vascular smooth muscle, causing smooth muscle relaxation, profound vasodilation, and reflex sympathetic stimulation. Indicated for severe, refractory hypertension that has failed to respond to multidrug regimens (administered with a beta-blocker and loop diuretic), and used off-label in low doses for refractory androgenetic alopecia under strict specialist oversight.